GLP-1 medications, or GLP-1 receptor agonists, are drugs created to treat people with Type 2 diabetes and help manage their blood sugar levels
Common reported effects in clinical use include mild injection site reactions with subcutaneous administration, occasional digestive changes when taken orally, and rare reports of fatigue or dizziness
Comparative study of efficacy and safety of pregabalin and gabapentin in neuropathic pain
Detox pathways are supported, but energy production may still feel suboptimal
They are typically caused by changes in the gel-like substance (the vitreous) inside the eye
Kyle Wood, M.D, associate professor in the University of Alabama at Birmingham Department of Urology, explains what current evidence shows and why hydration remains essential for anyone using these medications